Dianthus Therapeutics, Inc. announced that Lei Meng, a current Class III Director, will not stand for reelection at the Annual Meeting.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
27.77 USD | +6.77% | +8.74% | +150.10% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+150.10% | 763M | |
+4.77% | 111B | |
+12.07% | 105B | |
-12.65% | 22.34B | |
-3.70% | 21.93B | |
-6.03% | 18.59B | |
-35.21% | 18.12B | |
-10.59% | 16.96B | |
+4.16% | 13.7B | |
+37.21% | 12.45B |
- Stock Market
- Equities
- DNTH Stock
- News Dianthus Therapeutics, Inc.
- Lei Meng Announces Not to Stand for Reelection as Director of Dianthus Therapeutics, Inc